SCHEMBL6023331

SCHEMBL6023331

CCC(C)Oc1ccccc1-c1cccc(OC(=O)NC)c1C(C)CC

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
ACHE P22303 1/20 0.49
PGR P06401 1/20 0.43
GAA P10253 1/20 0.43
PTGS1 P23219 1/20 0.43
MAPK1 P28482 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.35
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
MCHR1 Q99705 1/20 0.34
DHODH Q02127 3/20 0.34
FAAH O00519 1/20 0.33
CXCR5 P32302 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5569807 0.82 ALDH1A1 (0.71) ALDH1A1ACHEPGRGAAPTGS1
SCHEMBL11207617 0.75 ALDH1A1 (0.79) ALDH1A1ACHEPGRGAAPTGS1
Fenobucarb SCHEMBL29368514 0.74 ALDH1A1 (0.58) ALDH1A1ACHEPGRGAAPTGS1
Fenobucarb SCHEMBL6740176 0.74 ALDH1A1 (0.58) ALDH1A1ACHEPGRGAAPTGS1
Fenobucarb SCHEMBL73674 0.74 ALDH1A1 (0.58) ALDH1A1ACHEPGRGAAPTGS1
Fenobucarb SCHEMBL6446466 0.72 ALDH1A1 (0.47) ALDH1A1ACHEPGRGAAPTGS1
SCHEMBL11852286 0.69 ALDH1A1 (0.64) ALDH1A1ACHEPGRGAAPTGS1
SCHEMBL11848573 0.69 ALDH1A1 (0.68) ALDH1A1ACHEPGRGAAPTGS1
SCHEMBL11509640 0.69 ALDH1A1 (0.68) ALDH1A1ACHEPGRGAAPTGS1
SCHEMBL11855036 0.69 ALDH1A1 (0.62) ALDH1A1ACHEPGRGAAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651034-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2006-05-03 EP disclosed
WO-2005013687-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2005-02-17 WO disclosed